Power and Predictive Accuracy of Polygenic Risk Scores
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Polygenic scores have recently been used to summarise genetic effects among an ensemble of markers that do not individually achieve significance in a large-scale association study. Markers are selected using an initial training sample and used to construct a score in an independent replication sample by forming the weighted sum of associated alleles within each subject. Association between a trait and this composite score implies that a genetic signal is present among the selected markers, and the score can then be used for prediction of individual trait values. This approach has been used to obtain evidence of a genetic effect when no single markers are significant, to establish a common genetic basis for related disorders, and to construct risk prediction models. In some cases, however, the desired association or prediction has not been achieved. Here, the power and predictive accuracy of a polygenic score are derived from a quantitative genetics model as a function of the sizes of the two samples, explained genetic variance, selection thresholds for including a marker in the score, and methods for weighting effect sizes in the score. Expressions are derived for quantitative and discrete traits, the latter allowing for case/control sampling. A novel approach to estimating the variance explained by a marker panel is also proposed. It is shown that published studies with significant association of polygenic scores have been well powered, whereas those with negative results can be explained by low sample size. It is also shown that useful levels of prediction may only be approached when predictors are estimated from very large samples, up to an order of magnitude greater than currently available. Therefore, polygenic scores currently have more utility for association testing than predicting complex traits, but prediction will become more feasible as sample sizes continue to grow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A PD polygenic risk score was calculated using a weighted allele-counting approach (Dudbridge, 2013) based on known, common PD susceptibility loci, derived from the largest and most recent PD genome-wide association study (GWAS) meta-analysis (Nalls et al., 2014).”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Dudbridge, 2013
In the citing paper
“Assuming high genetic correlation between males and females, reduced SNP heritability in females suggests that higher PGS are required to reach the equivalent levels of genetic likelihood in males62.”
From Genetic correlates of phenotypic heterogeneity in autism (2022) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction to Quantitative Genetics.
Edwards, A. W. F., & Falconer, D. S. (1982) · Biometrics · doi:10.2307/2529912 · Cited by 21,447
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · cited 15×
“Schiz [3] MS [6] BrCa [14] PrCa [14] RA [9] Celiac [9] MI/CAD [9] T2D [9]”
BackgroundMethodResultInfluentialCommon SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446 · cited 2×
“In particular, shrinkage estimation is likely to improve power and correlation, as well as mean square error, by analysing all markers simultaneously rather than each one marginally [37].”
BackgroundAssociation analyses of 249,796 individuals reveal 18 new loci associated with body mass index
MAGIC, Speliotes, E. K., on behalf of Procardis Consortium, Willer, C. J., Berndt, S. I., Monda, K. L., Thorleifsson, G., Jackson, A. U., Allen, H. L., Lindgren, C. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.686 · Cited by 2,912
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425 · cited 4×
“The method yields estimates that are similar to those obtained by existing approaches [1,37].”
BackgroundInfluentialRuppert, D., Wand, M. P., & Carroll, R. J. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511755453 · Cited by 2,124
Hundreds of variants clustered in genomic loci and biological pathways affect human height
Lango Allen, H., Estrada, K., Lettre, G., Berndt, S. I., Weedon, M. N., Rivadeneira, F., Willer, C. J., Jackson, A. U., Vedantam, S., Raychaudhuri, S., et al. (2010) · Nature · doi:10.1038/nature09410 · Cited by 1,945
Genome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.943 · Cited by 1,344
Self-citation
Cited by
Items 401–500 of 1,001
Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia
Wang, S. ‐., Hsiao, P., Yeh, L., Liu, C., Liu, C. ‐., Hwang, T., Hsieh, M. H., Chien, Y., Lin, Y., Chandler, S. D., et al. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12401 · Cited by 39
“The applicability and limitations of the PRS approach has been summarized by a review (Maher 2015), and the power Genes, Brain and Behavior (2018) 17: 49–55 53 and predictive accuracy of PRS has also been well studied (Dudbridge 2013).”
BackgroundMethodLarrieta‐Carrasco, E., Flóres, Y. N., Kauffer, L. R. M., Ramírez‐Palacios, P., Quiterio, M., Ramírez-Salazar, E. G., León‐Mimila, P., Rivera‐Paredez, B., Cabrera-Álvarez, G., Canizales‐Quinteros, S., et al. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.001 · Cited by 38
“To evaluate the combined effect of the SNPs that were significantly associated with higher ALT and AST levels, we constructed a polygenic risk score (PRS) (Dudbridge, 2013) for each individual, which included six SNPs: ADIPOQ rs17366743, COL13A1 (rs7101190 and rs1227756), PNPLA3 (rs3810622 and rs738409) and SAMM50 rs2…”
MethodPolygenic risk scoring and prediction of mental health outcomes
Anderson, J. S., Shade, J., DiBlasi, E., Shabalin, A. A., & Docherty, A. R. (2018) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.09.002 · Cited by 42
“those which include the majority of the genome in their calculation) improve predictive utility, yet such a strategy could produce overly-conservative estimates in certain conditions.[9] In the absence of an a priori optimal threshold, one may consider reading the formal analysis of thresholding recently published onl…”
BackgroundAttention Deficit Hyperactivity Disorder (ADHD) and Earnings in Later-Life Self-Employment
Patel, P. C., Rietveld, C. A., & Verheul, I. (2019) · Entrepreneurship Theory and Practice · doi:10.1177/1042258719888641 · Cited by 49
“A PRS is a weighted sum of genetic variants, and the weights are proportional to the estimated effect size of the genetic variant on the outcome of interest in a genome- wide association study (GWAS; Dudbridge, 2013).”
Backgroundde Villiers, C. B., Kroese, M., & Moorthie, S. A. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106763 · Cited by 45
“12 42 From A modEl To A sCorE PGS can be calculated using one of the methodologies discussed above.”
Non-parametric Polygenic Risk Prediction via Partitioned GWAS Summary Statistics
Chun, S., Imakaev, M., Hui, D., Patsopoulos, N. A., Neale, B. M., Kathiresan, S., Stitziel, N. O., & Sunyaev, S. R. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.05.004 · Cited by 38
“The variance of partitioned scores is approximately equal between case and control subjects since Gik of an individual partition explains only a small fraction of phenotypic variation on the observed scale in typical GWAS data.(31) Furthermore, due to the decorrelating property of eigenlocus projection, the covariance…”
BackgroundLamri, A., Mao, S., Desai, D., Gupta, M., Paré, G., & Anand, S. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65360-y · Cited by 38
Newbury, J. B., Arseneault, L., Caspi, A., Moffitt, T. E., Odgers, C. L., Belsky, D. W., Sugden, K., Williams, B., Ambler, A. P., Matthews, T., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720003347 · Cited by 48
Leveraging Multiple Layers of Data To Predict Drosophila Complex Traits
Morgante, F., Huang, W., Sørensen, P. B., Maltecca, C., & Mackay, T. F. C. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401847 · Cited by 42
“PRS are constructed as a weighted sum of the SNPs associated with the trait of interest from a genome wide association study (GWAS), with the estimated effects used as the weights (Dudbridge 2013; Wray et al. 2014).”
MethodMulti-omics approach to precision medicine for immune-mediated diseases
Ota, M., & Fujio, K. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00173-8 · Cited by 49
DeepNull models non-linear covariate effects to improve phenotypic prediction and association power
McCaw, Z. R., Colthurst, T., Yun, T., Furlotte, N. A., Carroll, A. W., Alipanahi, B., McLean, C. Y., & Hormozdiari, F. (2022) · Nature Communications · doi:10.1038/s41467-021-27930-0 · Cited by 48
Rodríguez, V., Alameda, L., Quattrone, D., Tripoli, G., Gayer-Anderson, C. E., Spinazzola, E., Trotta, G., Jongsma, H. E., Stilo, S. A., Cascia, C. L., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291721005456 · Cited by 45
“We can calculate individual polygenic risk scores (PRS) based on the summation of the carried risk of single nucleotide polymorphisms (SNPs) selected in a discovery GWAS according to their p -value, weighted by their effect size (Dudbridge, 2013; Purcell et al., 2009).”
The Role of Stress in Obsessive-Compulsive Disorder: A Narrative Review
Raposo-Lima, C., & Morgado, P. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000274 · Cited by 37
The GenoPred pipeline: a comprehensive and scalable pipeline for polygenic scoring
Pain, O., Al‐Chalabi, A., & Lewis, C. M. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae551 · Cited by 42
“A key application of GWAS findings is the development of polygenic scores, which aggregate the effects of numerous genetic variants across the genome to estimate an individual’s genetic predisposition to a given trait or disease (Dudbridge 2013, Choi et al. 2020).”
BackgroundErk, S., Meyer‐Lindenberg, A., Linden, D. E. J., Lancaster, T. M., Mohnke, S., Grimm, O., Degenhardt, F., Holmans, P., Pocklington, A. J., Schmierer, P., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.03.007 · Cited by 43
“Although the estimated proportion of genetic liability to schizophrenia explained by the polygenic score is smaller than the total polygenic contribution, due mainly to imprecision in estimating effect sizes (Dudbridge, 2013), it is still higher than that explained by any single variant.”
BackgroundGenetic Risks for Chronic Conditions: Implications for Long-term Wellbeing
Wehby, G. L., Domingue, B. W., & Wolinsky, F. D. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx154 · Cited by 44
Sørensen, H. J., Debost, J.-C., Agerbo, E., Benros, M. E., McGrath, J. J., Mortensen, P. B., Ranning, A., Hjorthøj, C. R., Mors, O. N., Nordentoft, M., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.012 · Cited by 41
Guo, W., Machado-Vieira, R., Mathew, S., Murrough, J. W., Charney, D. S., Grunebaum, M., Oquendo, M. A., Kadriu, B., Akula, N., Henter, I., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0311-7 · Cited by 38
Genomics and the Acute Respiratory Distress Syndrome: Current and Future Directions
Hernández-Beeftink, T., Guillén‐Guío, B., Villar, J., & Flores, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164004 · Cited by 37
“In this way, PRS can define the individual genetic risk of a patient to develop the disease based on the combined genetic risk variants identified from published GWAS results [97].”
BackgroundD’Abate, L., Walker, S., Yuen, R. K. C., Tammimies, K., Buchanan, J. A., Davies, R., Thiruvahindrapuram, B., Wei, J., Brian, J. A., Bryson, S. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13380-2 · Cited by 43
Generative network models of altered structural brain connectivity in schizophrenia
Zhang, X., Braun, U., Harneit, A., Zang, Z., Geiger, L. S., Betzel, R. F., Chen, J., Schweiger, J. I., Schwarz, K., Reinwald, J., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117510 · Cited by 48
Using DNA to predict behaviour problems from preschool to adulthood
Gidziela, A., Rimfeld, K., Malanchini, M., Allegrini, A. G., McMillan, A. J., Selzam, S., Ronald, A., Viding, E. M., von Stumm, S., Eley, T. C., et al. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13519 · Cited by 39
Tham, Y. C., Liao, J., Vithana, E. N., Khor, C. C., Teo, Y., Tai, E. S., Wong, T. Y., Aung, T., & Cheng, C. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.01.024 · Cited by 40
Initiative, A. D. N., Hao, X., Yao, X., Yan, J., Risacher, S. L., Saykin, A. J., Zhang, D., & Shen, L. (2016) · Neuroinformatics · doi:10.1007/s12021-016-9307-8 · Cited by 41
“Therefore, polygenic scores (Dudbridge, 2013; Sabuncu et al., 2012) that is considered as multi-locus genetic effect should be used in our DGMM model.”
Assessing the effects of 35 European‐derived BMI‐associated SNPs in Mexican children
Abadi, A., Peralta‐Romero, J., Suarez, F., Gómez-Zamudio, J. H., Burguete-García, A. I., Cruz, M., & Meyre, D. (2016) · Obesity · doi:10.1002/oby.21590 · Cited by 40
“An unweighted score was utilized because weighting does not have a major impact on the value of a GS (26,27).”
MethodMontesanto, A., Rango, F. D., Pirazzini, C., Guidarelli, G., Domma, F., Franceschi, C., & Passarino, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.04.008 · Cited by 44
Dezhina, Z., Ranlund, S. M., Kyriakopoulos, M., Williams, S., & Dima, D. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9879-z · Cited by 43
Polygenic risk score: use in migraine research
Chalmer, M. A., Esserlind, A.-L., Olesen, J., & Hansen, T. F. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0856-0 · Cited by 43
“For successful construction of the PRS four prerequisites has been suggested: The target and discovery samples must be large (n > 2000 [7]); the discovery sample must be at least as large as the target sample; the phenotype investigated must be relatively homogeneous; and the level of genetic variation explained by co…”
BackgroundMethodInfluentialGenetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence
Hiemstra, M., Nelemans, S. A., Branje, S., van Eijk, K. R., Hottenga, J., Vinkers, C. H., van Lier, P. A. C., Meeus, W., & Boks, M. P. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.024 · Cited by 42
“Although in many cases subsequent PRS thresholds did show significant results, to date the meaning of PRS based on low association alleles (thresholds 0.05–0.1) and ways to deal with multiple testing remain subject to debate (Dudbridge, 2013).”
BackgroundInfluentialPredicting quantitative traits from genome and phenome with near perfect accuracy
Märtens, K., Hallin, J., Warringer, J., Liti, G., & Parts, L. (2016) · Nature Communications · doi:10.1038/ncomms11512 · Cited by 39
A flexible and parallelizable approach to genome‐wide polygenic risk scores
Newcombe, P. J., Nelson, C. P., Samani, N. J., & Dudbridge, F. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22245 · Cited by 45
“Realizing the full potential of polygenic risk prediction will require much larger sample sizes than offered by a typical single cohort GWAS (Chatterjee et al., 2013; Dudbridge, 2013; Wray et al., 2013).”
Self-citationZhao, W., Palmer, C. E., Thompson, W. K., Chaarani, B., Garavan, H., Casey, B. J., Jernigan, T. L., Dale, A. M., & Fan, C. C. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa290 · Cited by 38
“fying psychiatric risk based on the polygenic burden of common variants (Purcell et al. 2009; Dudbridge 2013), fueling the discovery that complex behaviors are polygenic (Visscher et al.”
BackgroundPolygenic Risk Score of Longevity Predicts Longer Survival Across an Age Continuum
Tesi, N., van der Lee, S. J., Hulsman, M., Jansen, I. E., Stringa, N., van Schoor, N. M., Scheltens, P., van der Flier, W. M., Huisman, M. A., Reinders, M. J. T., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa289 · Cited by 44
“It is then the power of the parental longevity study, due to the large sample size, that determines replicability and predictability of the PRS (35).”
BackgroundPolygenic Scores for ADHD: A Meta-Analysis
Li, J. J., & He, Q. (2021) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-021-00774-4 · Cited by 37
“Conversely, setting a more conservative threshold, e.g. PT 0.01, captures less of the genetic signal but also fewer unassociated variants that may contribute to a noisy signal (Dudbridge, 2013).”
BackgroundInfluentialGenome-Wide Association of Heroin Dependence in Han Chinese
Kalsi, G., Euesden, J., Coleman, J. R. I., Ducci, F., Alıev, F., Newhouse, S., Liu, X., Ma, X., Wang, Y., Collier, D. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167388 · Cited by 35
“These small effect sizes, and the resultant lack of power, mean that the majority of disease associated SNPs fall below genome-wide significance; markers rejected by GWAS can be combined into quantitative scores to examine the combined effects of the variants [32,33].”
BackgroundJordan, D. M., & Do, R. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021136 · Cited by 35
Association of Common Genetic Variants with Lipid Traits in the Indian Population
Walia, G. K., Gupta, V., Aggarwal, A., Asghar, M., Dudbridge, F., Timpson, N. J., Nongmaithem, S. S., Kumar, M. R. C., Kinra, S., Prabhakaran, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101688 · Cited by 38
Self-citationBirnbaum, R., & Weinberger, D. R. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/rbirnbaum · Cited by 38
“A range of options for constructing a polygenic score may be considered, selection of markers according to their P-values in association studies, and different methods for weighting markers in the score.(77) Only a handful of studies utilizing a polygenic risk score have been reported to date, using both functional an…”
MethodAdiposity significantly modifies genetic risk for dyslipidemia
Cole, C. B., Nikpay, M., Lau, P., Stewart, A. F. R., Davies, R. W., Wells, G. A., Dent, R., & McPherson, R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p052522 · Cited by 42
Predictive accuracy of combined genetic and environmental risk scores
Dudbridge, F., Pashayan, N., & Yang, J. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22092 · Cited by 40
“Across six polygenic scores with different selection thresholds, the best fitting model (Palla & Dudbridge, 2015) has chip heritability 𝑅 2 𝐺𝑌 = 0 .”
InfluentialSelf-citationLett, T. A. P., Vogel, B. O., Ripke, S., Wackerhagen, C., Erk, S., Awasthi, S., Trubetskoy, V., Brandl, E. J., Mohnke, S., Veer, I. M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz270 · Cited by 39
Eskenazi, B., Ames, J., Rauch, S. A., Signorini, S. G., Brambilla, P., Mocarelli, P., Siracusa, C., Holland, N., & Warner, M. L. (2020) · Human Reproduction · doi:10.1093/humrep/deaa324 · Cited by 39
Cigarette smoking behaviors and the importance of ethnicity and genetic ancestry
Choquet, H., Yin, J., & Jorgenson, E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01244-7 · Cited by 41
Understanding the effects of education through the lens of biology
Sokolowski, H. M., & Ansari, D. (2018) · npj Science of Learning · doi:10.1038/s41539-018-0032-y · Cited by 35
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review
Khanna, N. N., Singh, M., Maindarkar, M. A., Kumar, A., Johri, A. M., Mantella, L. E., Laird, J. R., Paraskevas, K. I., Ruzsa, Z., Singh, N., et al. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e395 · Cited by 42
Polygenic Risk Scores for Glaucoma Onset in the Ocular Hypertension Treatment Study
Singh, R. K., Zhao, Y., Elze, T., Fingert, J. H., Gordon, M. O., Kass, M. A., Luo, Y., Pasquale, L. R., Scheetz, T. E., Segrè, A. V., et al. (2024) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2024.0151 · Cited by 43
Branched-chain amino acids and the risks of dementia, Alzheimer’s disease, and Parkinson’s disease
Fu, Y., Wang, Y., Ren, H., Guo, X., & Han, L. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1369493 · Cited by 42
“PRSs, which are based on the additive effect of multiple loci across the genome, may be better suited to capture the variance explained by common alleles (Dudbridge, 2013 et al., 2015).”
BackgroundVerduijn, J., Milaneschi, Y., Peyrot, W. J., Hottenga, J. J., Abdellaoui, A., de Geus, E. J. C., Smit, J. H., Breen, G., Lewis, C. M., Boomsma, D. I., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.024 · Cited by 35
“This higher explanatory power is attributable to the larger training set for GPRSSCZ (41); in a previous paper, we calculated that if we were to have the same size of training set for depression GPRS-MDD”
Arnau-Soler, A., Adams, M. J., Scotland, G., Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Hayward, C., & Thomson, P. A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209160 · Cited by 35
“This is consistent with the expectation that the larger the discovery sample (i.e. UKB), the greater the accuracy of the weighting and the more predictive the PRS [107].”
ResultGenetic basis of motoric cognitive risk syndrome in the Health and Retirement Study
Sathyan, S., Wang, T., Ayers, E. I., & Verghese, J. (2019) · Neurology · doi:10.1212/wnl.0000000000007141 · Cited by 37
“Individual level genetic predisposition is reflected by the polygenic score (PGS), constructed based on effect sizes of millions of single nucleotide polymorphisms (SNPs) derived from large GWAS conducted in the phenotype of interest.(9)”
MethodNewbury, D. F., Gibson, J. L., Conti‐Ramsden, G., Pickles, A. R., Durkin, K., & Toseeb, U. (2019) · Journal of Speech Language and Hearing Research · doi:10.1044/2019_jslhr-l-19-0001 · Cited by 47
“approach would increase the likelihood of constructing meaningful polygenic profiles within the moderate sample sizes available (Dudbridge, 2013).”
BackgroundBralten, J., Widomska, J., Witte, W. D., Yu, D., Mathews, C. A., Scharf, J. M., Buitelaar, J. K., Crosbie, J., Schachar, R. J., Arnold, P. D., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0793-y · Cited by 35
Canalization and Robustness in Human Genetics and Disease
Gibson, G. C., & Lacek, K. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022020-022327 · Cited by 37
den Hoed, M., Strawbridge, R. J., Almgren, P., Gustafsson, S., Axelsson, T., Engström, G., Fairé, U. D., Hedblad, B., Humphries, S. E., Lindgren, C. M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.032 · Cited by 36
“Using a GPS results in a higher statistical power when compared with the power to detect associations with individual loci [26].”
Polygenic Risk, Personality Dimensions, and Adolescent Alcohol Use Problems: A Longitudinal Study
Li, J. J., Savage, J. E., Kendler, K. S., Hickman, M., Mahedy, L., Macleod, J., Kaprio, J. A., Rose, R. J., & Dick, D. M. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.442 · Cited by 41
Johnson, E. C., Tillman, R., Alıev, F., Meyers, J. L., Salvatore, J. E., Anokhin, A. P., Dick, D. M., Edenberg, H. J., Kramer, J., Kuperman, S., et al. (2019) · Addiction · doi:10.1111/add.14512 · Cited by 38
“(typically P < 5e–8) in the discovery GWAS are still predicted to make small but incremental and additive contributions to risk liability for the outcome [20,38,39].”
BackgroundMethodAvinun, R., & Hariri, A. R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.008 · Cited by 37
Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia
Gasse, C., Wimberley, T., Wang, Y., Mors, O. N., Børglum, A. D., Als, T. D., Werge, T. M., Nordentoft, M., HOUGAARD, D. M., & Horsdal, H. T. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.08.008 · Cited by 33
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus
Dominguez, D., Kamphuis, S., Beyene, J., Wither, J., Harley, J., Blanco, I., Vila-Inda, C., Brunner, H., Klein-Gitleman, M., Mccurdy, D., et al. (2020) · Journal of Rheumatology · doi:10.3899/jrheum.200002 · Cited by 27
Genetic Risk, Muscle Strength, and Incident Stroke: Findings From the UK Biobank Study
Kim, Y., Hwang, S., Sharp, S. J., Luo, S., Yeung, S. L. A., & Teerlink, C. C. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.034 · Cited by 36
Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Alonso-González, A., Tosco-Herrera, E., Molina‐Molina, M., & Flores, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1152211 · Cited by 46
Methodologies underpinning polygenic risk scores estimation: a comprehensive overview
Sima, C. A. A. N., Step, K., Swart, Y., Schurz, H., Uren, C., & Möller, M. (2024) · Human Genetics · doi:10.1007/s00439-024-02710-0 · Cited by 38
“The approach takes advantage of the accuracy that can be achieved from large, well-powered European datasets and datasets showing similar LD patterns as the target population (Chatterjee et al., 2013; Dudbridge, 2013).”
BackgroundThe genomics of schizophrenia: Shortcomings and solutions
Zhuo, C., Hou, W., Li, G., Mao, F., Li, S., Lin, X., Jiang, D., Xu, Y. J., Tian, H., Wang, W., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.03.009 · Cited by 38
Ensink, J. B. M., de Moor, M. H. M., Zafarmand, M. H., de Laat, S., Uitterlinden, A. G., Vrijkotte, T. G. M., Lindauer, R., & Middeldorp, C. M. (2019) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32755 · Cited by 38
Ohi, K., Nishizawa, D., Shimada, T., Kataoka, Y., Hasegawa, J., Shioiri, T., Kawasaki, Y., Hashimoto, R., & Ikeda, K. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz073 · Cited by 38
Substance use: Interplay between polygenic risk and neighborhood environment
Pasman, J. A., Verweij, K. J. H., Abdellaoui, A., Hottenga, J., Fedko, I. O., Willemsen, G. A. H. M., Boomsma, D. I., & Vink, J. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107948 · Cited by 36
Gao, Y., Wei, Y., Zhou, X., Huang, S., Zhao, H., & Zeng, P. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.583106 · Cited by 35
Franco, N. R., Massi, M. C., Ieva, F., Manzoni, A., Paganoni, A. M., Zunino, P., Veldeman, L., Ost, P., Fonteyne, V., Talbot, C. J., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.03.024 · Cited by 36
“A PRS is calculated as a sum of phenotype-associated risk alleles, usually weighted by the effect sizes estimated from a genome-wide association study [3,4,5].”
MethodJoo, Y. Y., Moon, S., Wang, H., Kim, H., Lee, E., Kim, J. H., Posner, J. E., Ahn, W., Choi, I., Kim, J.-W., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.48585 · Cited by 38
Unique prediction of developmental psychopathology from genetic and familial risk
Loughnan, R. J., Palmer, C. E., Makowski, C., Thompson, W. K., Barch, D. M., Jernigan, T. L., Dale, A. M., & Fan, C. C. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13649 · Cited by 33
“PRS association strength is limited by the phenotype’s heritability and the training sample used (Dudbridge, 2013).”
BackgroundInouye, M., Abraham, G., Nelson, C. P., Wood, A., Sweeting, M. J., Dudbridge, F., Lai, F. Y., Kaptoge, S. K., Brożyńska, M., Wang, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/250712 · Cited by 33
“Second, because previous studies of GRSs have tended to have moderate statistical power, they have been unable to provide precise effect size estimates (10-12).”
BackgroundSelf-citationEthical layering in AI-driven polygenic risk scores—New complexities, new challenges
Fritzsche, M.-C., Akyüz, K., Abadía, M. C., McLennan, S., Marttinen, P., Mayrhofer, M. T., & Buyx, A. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1098439 · Cited by 46
“Early studies on PRSs (Purcell et al., 2009; Dudbridge, 2013) applied the so-called classic PRS method (Choi et al., 2020), where the risk is calculated as a weighted sum (i.e., a linear regression) of a set of genetic risk alleles for given single nucleotide polymorphisms (SNPs) (see also Figure…”
MethodDenis, M., Enquobahrie, D. A., Tadesse, M. G., Gelaye, B., Sánchez, S. E., Salazar, M., Ananth, C. V., & Williams, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116346 · Cited by 32
“These preliminary analyses are helpful to summarize identified effects of genetic variations, and could help in the construction of predictive models in future studies [77, 78].”
BackgroundKalman, J. L., Papiol, S., Forstner, A. J., Heilbronner, U., Degenhardt, F., Strohmaier, J., Adli, M., Adorjan, K., Akula, N., Alda, M., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12659 · Cited by 37
Albaugh, M. D., Hudziak, J. J., Ing, A., Chaarani, B., Barker, E. D., Jia, T., Lemaître, H., Watts, R., Orr, C., Spechler, P. A., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0383-y · Cited by 38
Fritsche, L. G., Beesley, L. J., VandeHaar, P., Peng, R. B., Salvatore, M., Zawistowski, M., Taliun, S. A. G., Das, S., LeFaive, J., Kaleba, E. O., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008202 · Cited by 36
“135 Incorporating non-significant variants may conceivably improve the predictive power of 136 a PRS but may also add additional random false positive signals, which in turn could 137 dilute the discriminatory power of the true risk variants and diminish any predictive gain 138 [8, 16].”
BackgroundInfluentialArtificial intelligence in genetic services delivery: Utopia or apocalypse?
Kearney, E., Wojcik, A., & Babu, D. (2019) · Journal of Genetic Counseling · doi:10.1002/jgc4.1192 · Cited by 38
“…version of machine learning is linear regression, which has been used in genome-wide association studies to determine the presence of single nucleotide polymorphisms and how they interact in complex disease (Dudbridge, 2013; Ho, Schierding, Wake, Saffery, & O'Sullivan, 2019; Szymczak et al., 2009).”
BackgroundMethodVelazquez-Roman, J. A., Zamudio, U. A. A., León-Sicairos, N. M., Serrano, J. M. M., DeLira-Bustillos, N., Villamil‐Ramírez, H., Canizales‐Quinteros, S., Kauffer, L. R. M., Campos‐Romero, A., Alcántar‐Fernández, J., et al. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108025 · Cited by 44
To Replicate or Not to Replicate: The Case of Pharmacogenetic Studies
Ioannidis, J. P. A. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000106 · Cited by 40
“The polygenic models would perform well if sufficiently large datasets can be accumulated.(29) Even though one cannot pinpoint which are the exact genes that make the difference among the top 1 00 000 variants that are considered, these influential genes are hidden as needles in a hay stack within the top 1 00 000 one…”
BackgroundHamad, R., Tuljapurkar, S. D., & Rehkopf, D. H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.015 · Cited by 38
“Prior research has suggested that analyses using a PRS may be more successful in predicting disease risk than use of individual genetic markers (Dudbridge, 2013).”
MethodHelicobacter pylori colonization and obesity – a Mendelian randomization study
den Hollander, W. J., Broer, L., Schurmann, C., Meyre, D., den Hoed, C. M., Mayerle, J. V., Albert Hofman, D., Homuth, G., Uitterlinden, A. G., Lerch, M. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14106-4 · Cited by 36
A Genetic Network Associated With Stress Resistance, Longevity, and Cancer in Humans
Levine, M. E., & Crimmins, E. M. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv141 · Cited by 33
Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
Paynter, N. P., Ridker, P. M., & Chasman, D. I. (2016) · Circulation Research · doi:10.1161/circresaha.115.306360 · Cited by 36
Marginal role for 53 common genetic variants in cardiovascular disease prediction
Morris, R. W., Cooper, J. A., Shah, T., Wong, A., Drenos, F., Engmann, J., McLachlan, S., Jefferis, B. J. M. H., Dale, C. E., Hardy, R., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309298 · Cited by 33
Self-citationPredicting risk of suicidal ideation in youth using a multigene panel for impulsive aggression
Koyama, E., Zai, C. C. H., Bryushkova, L., Kennedy, J. L., & Beitchman, J. H. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112726 · Cited by 35
Truong, B. M. T., Zhou, X., Shin, J., Li, J., van der Werf, J. H. J., Le, T. D., & Lee, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16829-x · Cited by 44
Reynolds, T., Johnson, E. C., Huggett, S. B., Bubier, J. A., Palmer, R. H. C., Agrawal, A., Baker, E. J., & Chesler, E. J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00795-5 · Cited by 33
“Likewise, the predictive power of a polygenic risk score (PRS), an index of aggregated genetic susceptibility to a disorder, for psychiatric disorders is also directly linked to the current statistical power of discovery GWAS [12].”
BackgroundPolygenic risk for anxiety influences anxiety comorbidity and suicidal behavior in bipolar disorder
Lopes, F. L., Zhu, K., Purves, K. L., Song, C., Ahn, K., Hou, L., Akula, N., Kassem, L., Bergen, S. E., Landén, M., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00981-5 · Cited by 33
Zhang, Z., Yang, X., Jia, Y., Wen, Y. F., Cheng, S., Meng, P., Li, C., Zhang, H., Pan, C., Zhang, J., et al. (2021) · Nutrients · doi:10.3390/nu13103343 · Cited by 32
“Polygenic risk score (PRS) is proposed by running a GWAS on a study sample, selecting SNPs according to the relevant phenotypes, and creating the sum of phenotype related alleles (usually weighted by the SNP-specific coefficients from the GWAS) that can be evaluated in other replication sample [24].”
BackgroundGordillo‐Marañón, M., Zwierzyna, M., Charoen, P., Drenos, F., Chopade, S., Shah, T., Engmann, J., Casas, J. P., Chaturvedi, N., Papacosta, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25731-z · Cited by 34
“instrument the exposure; and accounted for LD correlation by pruning and LD modelling during the MR analysis (12, 40).”
Genetics of Alzheimer’s Disease in the African American Population
Logue, M. W., Dasgupta, S., & Farrer, L. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165189 · Cited by 30
Chuang, L.-C., & Kuo, P. (2017) · Scientific Reports · doi:10.1038/srep39943 · Cited by 36
“Dudbridge and colleagues (2013) indicated that the power of polygenic score might be sufficient to use about 2,000 cases and controls, respectively 42 .”
BackgroundWolf, E. J., Miller, D. R., Logue, M. W., Sumner, J. A., Stoop, T. B., Leritz, E. C., Hayes, J. P., Stone, A., Schichman, S. A., McGlinchey, R. E., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.001 · Cited by 33
“Statistical Analyses Obesity PRS—PRSs are computed by obtaining the GWAS results from a study and using these results as weights to compute a single score reflecting the weighted average of genome-wide genotypes for subjects in a distinct sample (Purcell et al., 2009; Dudbridge, 2013).”
MethodInfluentialPolygenic risk for schizophrenia and season of birth within the UK Biobank cohort
Escott‐Price, V., Smıth, D. J., Kendall, K. M., Ward, J., Kirov, G., Owen, M. J., Walters, J., & O’Donovan, M. C. (2018) · Psychological Medicine · doi:10.1017/s0033291718000454 · Cited by 34
“AVENGEME provides a set of R functions that allow power for PRS analyses to be calculated (Dudbridge, 2013).”
BackgroundPharmacogenomic scores in psychiatry: systematic review of current evidence
Sharew, N. T., Clark, S. R., Schubert, K. O., & Amare, A. T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02998-6 · Cited by 40
“Second, SCZ GWASs are well-powered, including cases and controls of diverse ancestral background [79, 80], leading to more accurate PGSs [81].”
BackgroundMethodJayasinghe, D., Eshetie, S., Beckmann, K., Benyamin, B., & Lee, S. (2024) · Human Genetics · doi:10.1007/s00439-024-02716-8 · Cited by 36
“…l a ti on s hou l d a dd iti on a ll y b e p e rf o r m e d u s i ng P L I NK - - s c o r e f un c ti on They typically require large GWAS samples (Dudbridge 2013) and ancestry-matched LD reference panels, which may not be available for all populations, particularly admixed or genetically diverse…”
Clarke, T., Hall, L. S., Fernandez-Pujals, A. M., MacIntyre, D. J., Thomson, P. A., Hayward, C., Smith, B. H., Padmanabhan, S., Hocking, L. J., Deary, I. J., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.83 · Cited by 32
Lancaster, T. M., Ihssen, N., Brindley, L. M., Tansey, K. E., Mantripragada, K. K., O’Donovan, M. C., Owen, M. J., & Linden, D. E. J. (2015) · Human Brain Mapping · doi:10.1002/hbm.23044 · Cited by 31
“The former point is important as using summary statistics from larger data sets such as schizophrenia PGC2 (Schizophrenia Working Group of the Psychiatric Genomics, 2014) enhances the power and predictive capacity in discovery samples [Dudbridge, 2013].”
BackgroundResultGenetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Willoughby, A., Andreassen, P. R., & Toland, A. E. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010015 · Cited by 34
“A polygenic risk score (PRS), which combines the effect of many risk variants, is calculated through a weighted sum of the variants’ effects on overall risk of disease in combination with the frequency of that variant in the population [130].”
BackgroundKępińska, A. P., MacCabe, J. H., Cadar, D., Steptoe, A., Murray, R. M., & Ajnakina, O. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01114-8 · Cited by 32
Metadata
- Authors
- Dudbridge, F.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Dudbridge, Frank
- ORCID
- Dudbridge, Frank
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-21
- Volume
- 9
- Issue
- 3
- Pages
- e1003348
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3605113
- OpenAlex
- W1997338841
- Cited by
- 1,509
- References
- 45
- Citations by year
- 2026: 59 · 2025: 70 · 2024: 107 · 2023: 133 · 2022: 136 · 2021: 166 · 2020: 158 · 2019: 177 · 2018: 140 · 2017: 133 · 2016: 100 · 2015: 74 · 2014: 43 · 2013: 13
- FWCI
- 50.81
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-04-19)
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Medical Research Council (MR/K006215/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- polygenic risk score, statistical power, prediction accuracy, genetic variance explained, case-control sampling, sample size, complex traits, genetic association testing
- MeSH terms
- Humans, Models, Theoretical, Linear Models, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.